drugset / Trial / NCT02228239
Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants
RandomizedCrossoverDouble-blindPrevention
Summary
The purpose of this study is to evaluate the effect of esketamine compared to placebo on driving performance as assessed by the mean difference of standard deviation of lateral position (SDLP) from an on-road driving test in healthy participants.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 84 mg | Intranasal |
| Subject | Mirtazapine | Other / unclassified | 30 mg | Oral |
Indications
No indication recorded.